Online citations, reference lists, and bibliographies.

Pancreatic Neuroendocrine Tumors: The Impact Of Surgical Resection On Survival.

Joshua S. Hill, James T. McPhee, Theodore P. McDade, Zheng Zhou, Mary E. Sullivan, Giles Francis Whalen, Jennifer Tseng
Published 2009 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
BACKGROUND Although surgical resection is generally recommended for patients with localized pancreatic neuroendocrine tumors (PNETs), the impact of resection on overall survival is unknown. The authors investigated the survival advantage of pancreatic resection using a national database. METHODS This is a retrospective survival analysis of patients with PNETs from the Surveillance, Epidemiology, and End Results database (1988-2002). RESULTS A total of 728 patients with PNETs were identified with a median survival of 43 months using Kaplan-Meier survival methods. Resection of tumor was associated with significantly improved survival compared with those patients who were recommended for but did not undergo resection (114 months vs 35 months; P < .0001). This survival benefit was demonstrated for patients with localized, regional, and metastatic disease. A multivariable Cox proportional hazards model was constructed to assess the overall effect of surgical resection on survival, and demonstrated an adjusted odds ratio of 0.48 (95% confidence interval, 0.35-0.66) compared with those who were recommended for surgery but did not proceed to surgery. CONCLUSIONS The authors have demonstrated in a large national study that resection of primary tumor in patients with PNETs is associated with improved survival across all disease stages. Patients with localized, regional, and metastatic PNETs who are reasonable operative candidates should be considered for resection of their primary tumors.

This paper is referenced by
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.
Stefano Crippa (2014)
EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat?
Alberto Larghi (2019)
Potential Benefit of Resection for Stage IV Gastric Cancer: A National Survey
Jillian K. Smith (2010)
Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
Alain Sauvanet (2019)
Guideline for the Management of Pancreatic Neuroendocrine Tumor
Gabriele Spoletini (2017)
Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Yaqing Sun (2020)
Pancreatic neuroendocrine neoplasms: The latest surgical and medical treatment strategies based on the current World Health Organization classification.
Hirotaka Ishida (2019)
Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms.
Alexander Kaltenborn (2016)
Surgical Resection and Multidisciplinary Care for Primary and Metastatic Pancreatic Islet Cell Carcinomas
Shaun P McKenzie (2010)
Impact of 68Ga-DOTATATE PET/CT on the Surgical Management of Primary Neuroendocrine Tumors of the Pancreas or Ileum
Harun Ilhan (2014)
Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors
Yu Yong Jiang (2015)
Nonfunctioning, small, incidental pancreatic neuroendocrine tumors: Results of a nonoperative approach cohort.
Catalina Uribe Galeano (2017)
Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry
Nehara Begum (2020)
High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor
Yoon Suk Lee (2015)
Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
Tahsin Khan (2016)
Surgical Management of Pancreatic Neuroendocrine Tumors.
Tanaz Vaghaiwalla (2020)
Intraductal Growth of a Pancreatic Glucagonoma
Tatsuto Terada (2016)
57. Zollinger–Ellison Syndrome
Robert T. Jensen (2015)
Klassifikation und malignes Potenzial der zystischen Pankreastumoren
I. Esposito (2014)
Advances in the management and treatment of gastroenteropancreatic neuroendocrine tumors
Eric Feliberti (2011)
Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy
Song Kim (2009)
99mTc-HYNIC-TOC imaging in the evaluation of pancreatic masses which are potential neuroendocrine tumors.
Zhen Qiao (2015)
[Endocrine surgery during and after the COVID-19 epidemic: guidelines from AFCE].
Grégory Baud (2020)
Long-term survival after surgical management of neuroendocrine hepatic metastases.
Evan S Glazer (2010)
S2k-Leitlinie Neuroendokrine Tumore
Verdauungs und Stoffwechselkrankheiten Deutsche Gesellschaft Gastroenterologie (2018)
Incremental benefit of preoperative EUS for the detection of pancreatic neuroendocrine tumors: a meta-analysis.
Paul Damien James (2015)
Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems
Ewa Pomianowska (2010)
Surgery for Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases
Mark S. Etherington (2019)
Surgical strategy for neuroendocrine liver metastases
Andrew K. Y. Fung (2019)
Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
Lauren McLendon Postlewait (2016)
A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours
Mohammad Adil (2015)
Primary small cell neuroendocrine carcinoma of adrenal gland
Kosuke Ogawa (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar